Aemcolo
These highlights do not include all the information needed to use AEMCOLO safely and effectively. See full prescribing information for AEMCOLO. AEMCOLO (rifamycin) delayed-release tablets, for oral use. Initial U.S. Approval: 2018
b31ff668-ee1f-4d89-8b69-68df2a0d2243
HUMAN PRESCRIPTION DRUG LABEL
Dec 15, 2023
RedHill Biopharma Ltd
DUNS: 533278342
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Rifamycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Rifamycin
Product Details
FDA regulatory identification and product classification information